Carinna Hockham's Publications

About Carinna Hockham's Publications

Postdoctoral Research Associate in Epidemiology
  • BA, MSc, DPhil

  • Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

    Trials Date published:

  • Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program

    Diabetologia Date published:

  • Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

    Unknown Date published:

  • Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease

    Circulation Date published:

  • Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria

    Clinical Journal of the American Society of Nephrology Date published:

  • Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data

    Journal of Clinical & Translational Endocrinology Date published:

  • The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review

    European Heart Journal - Quality of Care and Clinical Outcomes Date published:

  • Therapy Escalation Following an Elevated HbA1c in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-World Observational Analysis

    Diabetes Care Date published:

  • What Sex-Disaggregated Metrics Are Needed to Explain Sex Differences in COVID-19?

    Frontiers in Global Women's Health Date published:

  • Where are the women? Gender inequalities in COVID-19 research authorship

    BMJ Global Health Date published:

  • P1028EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIFFERENT BASELINE LEVELS OF TYPE 2 DIABETES MELLITUS DISEASE SEVERITY: RESULTS FROM THE CANVAS PROGRAM

    Nephrology Dialysis Transplantation Date published:

  • P1019CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL

    Nephrology Dialysis Transplantation Date published:

  • P1013CANAGLIFLOZIN AND RISK OF GENITAL INFECTIONS AND URINARY TRACT INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE- A POST-HOC ANALYSIS OF THE CREDENCE TRIAL

    Nephrology Dialysis Transplantation Date published:

  • EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study

    JMIR Research Protocols Date published:

  • Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 Study

    Diabetes Care Date published:

  • Estimating the burden of α-thalassaemia in Thailand using a comprehensive prevalence database for Southeast Asia

    eLife Date published: